138 related articles for article (PubMed ID: 34688316)
1. Preparation and Properties of Thrombus-Targeted Urokinase/Multi-Walled Carbon Nanotubes (MWCNTs)-Chitosan (CS)-RGD Drug Delivery System.
Zhang R; Luo S; Hao LK; Jiang YY; Gao Y; Zhang NN; Zhang XC; Song YM
J Biomed Nanotechnol; 2021 Sep; 17(9):1711-1725. PubMed ID: 34688316
[TBL] [Abstract][Full Text] [Related]
2. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.
Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y
Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of thrombus-targeted urokinase liposomes and its thrombolytic effect in model rats].
Wang XT; Li S; Zhang XB; Hou XP
Yao Xue Xue Bao; 2003 Mar; 38(3):231-5. PubMed ID: 12830724
[TBL] [Abstract][Full Text] [Related]
4. A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Huang Y; Jiang J; Ren J; Guo Y; Zhao Q; Zhou J; Li Y; Chen R
Adv Healthc Mater; 2022 Oct; 11(19):e2201265. PubMed ID: 35864062
[TBL] [Abstract][Full Text] [Related]
5. Effective deactivation of A549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel.
Li B; Zhang XX; Huang HY; Chen LQ; Cui JH; Liu Y; Jin H; Lee BJ; Cao QR
Int J Pharm; 2018 May; 543(1-2):8-20. PubMed ID: 29535039
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible multi-walled carbon nanotube-chitosan-folic acid nanoparticle hybrids as GFP gene delivery materials.
Liu X; Zhang Y; Ma D; Tang H; Tan L; Xie Q; Yao S
Colloids Surf B Biointerfaces; 2013 Nov; 111():224-31. PubMed ID: 23831590
[TBL] [Abstract][Full Text] [Related]
7. Poly-
Chen S; Liang M; Wu C; Zhang X; Wang Y; Zhao M
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985552
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo.
Jin HJ; Zhang H; Sun ML; Zhang BG; Zhang JW
J Thromb Thrombolysis; 2013 Nov; 36(4):458-68. PubMed ID: 23728739
[TBL] [Abstract][Full Text] [Related]
9. A thrombolytic therapy using diagnostic ultrasound combined with RGDS-targeted microbubbles and urokinase in a rabbit model.
Guan L; Wang C; Yan X; Liu L; Li Y; Mu Y
Sci Rep; 2020 Jul; 10(1):12511. PubMed ID: 32719362
[TBL] [Abstract][Full Text] [Related]
10. Experimental study of the preparation of targeted microbubble contrast agents carrying urokinase and RGDS.
Mu Y; Li L; Ayoufu G
Ultrasonics; 2009 Dec; 49(8):676-81. PubMed ID: 19559452
[TBL] [Abstract][Full Text] [Related]
11. Targeted thrombolysis by using c-RGD-modified N,N,N-Trimethyl Chitosan nanoparticles loaded with lumbrokinase.
Liao J; Ren X; Yang B; Li H; Zhang Y; Yin Z
Drug Dev Ind Pharm; 2019 Jan; 45(1):88-95. PubMed ID: 30198790
[TBL] [Abstract][Full Text] [Related]
12. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
13. RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy.
Xu Z; Huang J; Zhang T; Xu W; Liao X; Wang Y; Wang G
J Mater Sci Mater Med; 2023 Apr; 34(4):18. PubMed ID: 37043085
[TBL] [Abstract][Full Text] [Related]
14. Dual drive mode polydopamine nanomotors for continuous treatment of an inferior vena cava thrombus.
Fang D; Li T; Wu Z; Wang Q; Wan M; Zhou M; Mao C
J Mater Chem B; 2021 Oct; 9(41):8659-8666. PubMed ID: 34608926
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a novel nanoparticle carrying urokinase used in targeted thrombolysis.
Zhong Y; Gong WJ; Gao XH; Li YN; Liu K; Hu YG; Qi JS
J Biomed Mater Res A; 2020 Feb; 108(2):193-200. PubMed ID: 31581363
[TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis.
Zhang N; Li C; Zhou D; Ding C; Jin Y; Tian Q; Meng X; Pu K; Zhu Y
Acta Biomater; 2018 Apr; 70():227-236. PubMed ID: 29412186
[TBL] [Abstract][Full Text] [Related]
17. Combined Low-Frequency Ultrasound and Urokinase-Containing Microbubbles in Treatment of Femoral Artery Thrombosis in a Rabbit Model.
Zhu Y; Guan L; Mu Y
PLoS One; 2016; 11(12):e0168909. PubMed ID: 28033371
[TBL] [Abstract][Full Text] [Related]
18. Transactivator of transcription (TAT) peptide- chitosan functionalized multiwalled carbon nanotubes as a potential drug delivery vehicle for cancer therapy.
Dong X; Liu L; Zhu D; Zhang H; Leng X
Int J Nanomedicine; 2015; 10():3829-40. PubMed ID: 26082633
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for
Li J; Zhang X; Mo Y; Huang T; Rao H; Tan Z; Huang L; Zeng D; Jiang C; Zhong Y; Cai Y; Liang B; Wu J
Front Bioeng Biotechnol; 2022; 10():1038829. PubMed ID: 36324896
[No Abstract] [Full Text] [Related]
20. Drug targeting to arthritic region via folic acid appended surface-engineered multi-walled carbon nanotubes.
Kayat J; Mehra NK; Gajbhiye V; Jain NK
J Drug Target; 2016; 24(4):318-27. PubMed ID: 26289435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
